Our present study was designed to investigate the underlying mechanism of LBDE against CCl4-induced hepatic fibrosis and its relationship with activation of COX-2 and NF-κB in in-vitro and in-vivo. This evidence concerns the gene NFKB1 and Hepatic fibrosis.